TOLTERODINE

TOLTERODINE was reported 8981 times

TOLTERODINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLADDER ADENOCARCINOMA STAGE UNSPECIFIED 5 0.1064
1 ANTICHOLINERGIC SYNDROME 116 0.0728
2 SERUM AMYLOID A PROTEIN INCREASED 5 0.0323
3 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED 4 0.0238
4 AUTOINFLAMMATORY DISEASE 5 0.0236
5 EAR INFECTION FUNGAL 7 0.0232
6 ILIAC ARTERY OCCLUSION 4 0.0145
7 DRUG WITHDRAWAL HEADACHE 4 0.0096
8 HYPERTONIC BLADDER 27 0.0093
9 OESOPHAGEAL OBSTRUCTION 8 0.0092
10 THYROXINE FREE DECREASED 5 0.0088
11 PERFORATION 7 0.0087
12 BLADDER OBSTRUCTION 4 0.0078
13 NEUTROPHIL COUNT ABNORMAL 20 0.0071
14 MASTICATION DISORDER 21 0.0069
15 ABSCESS JAW 7 0.0067
16 BLOOD IMMUNOGLOBULIN G INCREASED 8 0.0066
17 RECTAL TENESMUS 8 0.0064
18 CLAUSTROPHOBIA 7 0.0064
19 BLADDER SPASM 12 0.0064
20 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 5 0.0063
21 BLADDER DYSFUNCTION 6 0.0058
22 PROGRESSIVE MULTIPLE SCLEROSIS 6 0.0052
23 DRY AGE-RELATED MACULAR DEGENERATION 5 0.0045
24 SERONEGATIVE ARTHRITIS 5 0.0044
25 BLADDER OPERATION 5 0.0043
26 NEUROGENIC BLADDER 8 0.0038
27 BLADDER DISORDER 37 0.0037
28 B-LYMPHOCYTE COUNT DECREASED 5 0.0037
29 BODY TEMPERATURE FLUCTUATION 7 0.0034
30 WHITE BLOOD CELL COUNT ABNORMAL 21 0.0033
31 BLADDER PROLAPSE 4 0.0033
32 HAEMOGLOBIN ABNORMAL 21 0.0033
33 ALLERGY TO CHEMICALS 4 0.0032
34 HALLUCINATIONS, MIXED 13 0.0031
35 LIPOMA 8 0.0031
36 URINARY INCONTINENCE 87 0.0029
37 CHOREA 5 0.0029
38 SERUM FERRITIN DECREASED 5 0.0029
39 MICROCYTIC ANAEMIA 6 0.0029
40 ALVEOLITIS 4 0.0028
41 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
42 OESOPHAGEAL STENOSIS 8 0.0028
43 BLOOD PRESSURE DIASTOLIC ABNORMAL 7 0.0027
44 HAEMORRHAGE URINARY TRACT 7 0.0027
45 COCCYDYNIA 4 0.0027
46 OESOPHAGITIS 29 0.0027
47 ORTHOSTATIC HYPOTENSION 46 0.0026
48 FACE INJURY 10 0.0026
49 OESOPHAGEAL ULCER 10 0.0026
50 MUSCLE FATIGUE 11 0.0026
51 NEPHROGENIC ANAEMIA 12 0.0026
52 ORAL FUNGAL INFECTION 7 0.0026
53 MACULOPATHY 9 0.0025
54 INJECTION SITE NECROSIS 5 0.0025
55 ANTIBODY TEST POSITIVE 4 0.0024
56 URINARY RETENTION 80 0.0024
57 HYPERPARATHYROIDISM SECONDARY 6 0.0024
58 COLITIS ISCHAEMIC 16 0.0024
59 PARKINSON'S DISEASE 6 0.0024
60 ANAEMIA MACROCYTIC 5 0.0023
61 NORMOCHROMIC NORMOCYTIC ANAEMIA 7 0.0023
62 VITREOUS DETACHMENT 5 0.0023
63 COLONOSCOPY 5 0.0023
64 NOSOCOMIAL INFECTION 5 0.0023
65 FACIAL PARESIS 8 0.0023
66 AREFLEXIA 6 0.0022
67 FUNGAL SKIN INFECTION 9 0.0022
68 GASTROINTESTINAL SOUNDS ABNORMAL 11 0.0022
69 BLADDER PAIN 7 0.0022
70 ESSENTIAL HYPERTENSION 4 0.0022
71 CALCIPHYLAXIS 4 0.0022
72 SPINAL STENOSIS 9 0.0022
73 ACCIDENTAL DEATH 4 0.0022
74 POTENTIATING DRUG INTERACTION 7 0.0021
75 COMA SCALE ABNORMAL 6 0.0021
76 RETROPERITONEAL HAEMORRHAGE 5 0.0020
77 ACUTE PSYCHOSIS 5 0.0020
78 MUCOUS STOOLS 10 0.0020
79 CEREBRAL ATROPHY 8 0.0020
80 INCONTINENCE 21 0.0020
81 PERONEAL NERVE PALSY 11 0.0019
82 CATHETER SITE PAIN 5 0.0019
83 FAILURE TO THRIVE 10 0.0019
84 NON-CARDIAC CHEST PAIN 6 0.0019
85 DECREASED INTEREST 11 0.0019
86 DRY MOUTH 151 0.0019
87 PEMPHIGOID 14 0.0019
88 TONGUE DISCOLOURATION 8 0.0018
89 NEUTROPENIC SEPSIS 13 0.0018
90 DRY THROAT 18 0.0018
91 SUBARACHNOID HAEMORRHAGE 18 0.0018
92 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
93 MYASTHENIA GRAVIS 14 0.0017
94 NOCTURIA 21 0.0017
95 FINE MOTOR SKILL DYSFUNCTION 5 0.0017
96 COORDINATION ABNORMAL 24 0.0017
97 DISTURBANCE IN SOCIAL BEHAVIOUR 4 0.0017
98 WALKING AID USER 11 0.0017
99 MOTOR DYSFUNCTION 17 0.0017
100 ANAL INCONTINENCE 15 0.0017
101 CYSTITIS 53 0.0017
102 REBOUND ACID HYPERSECRETION 5 0.0017
103 POLLAKIURIA 68 0.0016
104 UROSEPSIS 15 0.0016
105 DYSARTHRIA 60 0.0016
106 LOSS OF CONTROL OF LEGS 6 0.0016
107 ELECTROENCEPHALOGRAM ABNORMAL 5 0.0016
108 MICTURITION URGENCY 18 0.0016
109 COMMUNICATION DISORDER 6 0.0016
110 STUPOR 5 0.0016
111 AORTIC ARTERIOSCLEROSIS 4 0.0016
112 BLOOD CHLORIDE DECREASED 4 0.0015
113 RALES 9 0.0015
114 DRUG TITRATION ERROR 4 0.0015
115 SINUS TACHYCARDIA 22 0.0015
116 VITAMIN D DEFICIENCY 15 0.0015
117 PHARYNGEAL SWELLING 15 0.0015
118 LISTLESS 5 0.0015
119 NERVE COMPRESSION 14 0.0015
120 DRUG INTERACTION 240 0.0015
121 HYPOMAGNESAEMIA 21 0.0015
122 ENURESIS 6 0.0015
123 BLOOD SODIUM INCREASED 4 0.0015
124 BK VIRUS INFECTION 5 0.0015
125 FAECALOMA 8 0.0015
126 SEROTONIN SYNDROME 28 0.0015
127 FOOT DEFORMITY 16 0.0014
128 MULTIPLE SCLEROSIS 69 0.0014
129 MICTURITION DISORDER 5 0.0014
130 CHOLECYSTITIS INFECTIVE 4 0.0014
131 HYPERREFLEXIA 5 0.0014
132 BODY TEMPERATURE DECREASED 14 0.0014
133 HANGOVER 5 0.0014
134 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
135 DYSURIA 52 0.0014
136 FORCED EXPIRATORY VOLUME DECREASED 4 0.0014
137 INJECTION SITE SCAR 4 0.0014
138 MULTIPLE ALLERGIES 11 0.0014
139 SALIVARY HYPERSECRETION 14 0.0014
140 TEARFULNESS 6 0.0014
141 HIATUS HERNIA 18 0.0014
142 FIBULA FRACTURE 4 0.0014
143 HYPONATRAEMIA 78 0.0014
144 IMMOBILE 6 0.0014
145 BLOOD DISORDER 11 0.0014
146 MENTAL IMPAIRMENT 33 0.0014
147 VARICOSE VEIN 7 0.0014
148 WHEELCHAIR USER 6 0.0013
149 ATYPICAL PNEUMONIA 4 0.0013
150 HYPERCAPNIA 4 0.0013
151 HEAD INJURY 42 0.0013
152 BALANCE DISORDER 114 0.0013
153 HOSPICE CARE 13 0.0013
154 DYSCHEZIA 4 0.0013
155 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
156 ANAL FISSURE 7 0.0013
157 OVERWEIGHT 7 0.0013
158 THYROID MASS 5 0.0013
159 URINARY TRACT INFECTION 221 0.0013
160 THERAPEUTIC PRODUCT EFFECT VARIABLE 5 0.0013
161 BLOOD PRESSURE SYSTOLIC INCREASED 25 0.0013
162 FALL 425 0.0013
163 SKIN ABRASION 6 0.0013
164 MULTIPLE SCLEROSIS RELAPSE 87 0.0013
165 ABDOMINAL ADHESIONS 4 0.0013
166 SLEEP APNOEA SYNDROME 24 0.0013
167 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
168 SCAB 14 0.0012
169 BODY HEIGHT DECREASED 13 0.0012
170 INFLAMMATORY MARKER INCREASED 6 0.0012
171 ABDOMINAL TENDERNESS 6 0.0012
172 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
173 HYDRONEPHROSIS 9 0.0012
174 HALLUCINATION 90 0.0012
175 QUALITY OF LIFE DECREASED 16 0.0012
176 INTERNATIONAL NORMALISED RATIO INCREASED 34 0.0012
177 HALLUCINATION, VISUAL 25 0.0012
178 B-CELL LYMPHOMA 4 0.0012
179 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
180 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
181 PROSTATIC SPECIFIC ANTIGEN INCREASED 16 0.0012
182 CERVICAL VERTEBRAL FRACTURE 4 0.0012
183 METASTATIC NEOPLASM 5 0.0012
184 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
185 HYPOPNOEA 4 0.0012
186 SERUM FERRITIN INCREASED 6 0.0011
187 SCOLIOSIS 7 0.0011
188 BACTERIAL INFECTION 21 0.0011
189 PRE-EXISTING CONDITION IMPROVED 7 0.0011
190 ILEUS PARALYTIC 5 0.0011
191 SUBDURAL HAEMATOMA 16 0.0011
192 POLYURIA 9 0.0011
193 RASH PUSTULAR 8 0.0011
194 APHASIA 33 0.0011
195 MYOCLONUS 13 0.0011
196 HYPERKERATOSIS 6 0.0011
197 CONFUSIONAL STATE 175 0.0011
198 ON AND OFF PHENOMENON 6 0.0011
199 HEAD DISCOMFORT 19 0.0011
200 PERIORBITAL SWELLING 6 0.0011
201 DYSPHAGIA 100 0.0011
202 CLAVICLE FRACTURE 4 0.0010
203 MUSCLE TWITCHING 24 0.0010
204 MOUTH SWELLING 6 0.0010
205 RENAL PAIN 11 0.0010
206 HUMERUS FRACTURE 5 0.0010
207 SPEECH DISORDER 54 0.0010
208 URINE OUTPUT DECREASED 9 0.0010
209 FAECES HARD 4 0.0010
210 EPIGASTRIC DISCOMFORT 4 0.0010
211 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
212 LIP SWELLING 34 0.0010
213 SKIN LACERATION 11 0.0010
214 ASPIRATION 11 0.0010
215 MUSCLE RIGIDITY 12 0.0010
216 PROTHROMBIN TIME PROLONGED 6 0.0010
217 PROTEIN URINE PRESENT 5 0.0010
218 HEPATIC ENZYME ABNORMAL 5 0.0010
219 EMPHYSEMA 10 0.0010
220 OPTIC NEURITIS 9 0.0010
221 SEASONAL ALLERGY 14 0.0010
222 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
223 MUSCULAR WEAKNESS 112 0.0010
224 DIVERTICULUM 7 0.0010
225 DYSLIPIDAEMIA 5 0.0010
226 EPILEPSY 30 0.0010
227 INCREASED TENDENCY TO BRUISE 9 0.0010
228 FEMORAL NECK FRACTURE 5 0.0010
229 MOBILITY DECREASED 70 0.0010
230 THERAPY CESSATION 50 0.0010
231 LETHARGY 56 0.0010
232 TRISMUS 5 0.0010
233 CHOLANGITIS 6 0.0010
234 DELUSION 15 0.0010
235 CONGESTIVE CARDIOMYOPATHY 4 0.0010
236 BLOOD SODIUM DECREASED 18 0.0010
237 DRUG TOXICITY 13 0.0010
238 IMPAIRED GASTRIC EMPTYING 13 0.0010
239 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
240 GASTRIC ULCER 18 0.0009
241 HAEMATEMESIS 24 0.0009
242 JOINT DISLOCATION 10 0.0009
243 FEELING DRUNK 7 0.0009
244 FOREIGN BODY SENSATION IN EYES 6 0.0009
245 AORTIC VALVE INCOMPETENCE 4 0.0009
246 FACIAL PARALYSIS 8 0.0009
247 POST PROCEDURAL COMPLICATION 18 0.0009
248 DISORIENTATION 37 0.0009
249 FOOD POISONING 5 0.0009
250 ABASIA 23 0.0009
251 BRUXISM 5 0.0009
252 DISTURBANCE IN ATTENTION 50 0.0009
253 DECREASED ACTIVITY 10 0.0009
254 PSYCHOLOGICAL TRAUMA 8 0.0009
255 HAEMATOMA 24 0.0009
256 PYELONEPHRITIS 8 0.0009
257 PARKINSONISM 9 0.0009
258 EYE PAIN 52 0.0009
259 TRANSIENT ISCHAEMIC ATTACK 31 0.0009
260 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
261 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
262 DIVERTICULUM INTESTINAL 4 0.0009
263 MIDDLE INSOMNIA 17 0.0009
264 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
265 BLOOD CREATINE INCREASED 4 0.0009
266 CONSTIPATION 197 0.0009
267 TERMINAL STATE 6 0.0009
268 DELIRIUM 31 0.0009
269 HEMIPARESIS 15 0.0009
270 HYPERKALAEMIA 31 0.0009
271 RENAL CYST 7 0.0009
272 GRANULOCYTOPENIA 5 0.0009
273 RIB FRACTURE 18 0.0009
274 GAIT DISTURBANCE 167 0.0009
275 SENSORY DISTURBANCE 14 0.0009
276 HERPES VIRUS INFECTION 5 0.0009
277 LYMPHOEDEMA 6 0.0009
278 NEURALGIA 21 0.0009
279 EXTRASYSTOLES 6 0.0009
280 COGNITIVE DISORDER 40 0.0009
281 HYPOVOLAEMIA 5 0.0009
282 URINE ODOUR ABNORMAL 5 0.0008
283 BRADYKINESIA 5 0.0008
284 SPINAL COMPRESSION FRACTURE 7 0.0008
285 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
286 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
287 BLOOD URINE PRESENT 16 0.0008
288 CATARACT OPERATION 5 0.0008
289 PNEUMONIA ASPIRATION 21 0.0008
290 BLOOD UREA INCREASED 14 0.0008
291 IMPAIRED QUALITY OF LIFE 12 0.0008
292 WRIST FRACTURE 10 0.0008
293 FAECAL INCONTINENCE 4 0.0008
294 GASTROENTERITIS VIRAL 15 0.0008
295 VISION BLURRED 114 0.0008
296 MENTAL STATUS CHANGES 23 0.0008
297 ATELECTASIS 8 0.0008
298 HYPOKINESIA 12 0.0008
299 VERTIGO 50 0.0008
300 TOOTH FRACTURE 9 0.0008
301 MUSCLE SPASTICITY 10 0.0008
302 PAIN IN JAW 23 0.0008
303 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
304 CEREBRAL HAEMORRHAGE 29 0.0008
305 HYPERVOLAEMIA 4 0.0008
306 THINKING ABNORMAL 15 0.0008
307 HAIR COLOUR CHANGES 10 0.0008
308 ANEURYSM 4 0.0008
309 HYPERNATRAEMIA 4 0.0008
310 RENAL FAILURE ACUTE 34 0.0008
311 FLUID INTAKE REDUCED 4 0.0008
312 BLOOD POTASSIUM DECREASED 24 0.0008
313 PHOTOPHOBIA 15 0.0008
314 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
315 LIVER FUNCTION TEST ABNORMAL 23 0.0008
316 APHONIA 11 0.0008
317 HIP ARTHROPLASTY 12 0.0008
318 DRUG DELIVERY SYSTEM MALFUNCTION 4 0.0008
319 NEUTROPHIL COUNT INCREASED 8 0.0008
320 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
321 CEREBRAL ISCHAEMIA 4 0.0008
322 TEMPERATURE INTOLERANCE 8 0.0008
323 EYELID OEDEMA 9 0.0008
324 LIMB INJURY 21 0.0008
325 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
326 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
327 DYSPHONIA 45 0.0008
328 PALPITATIONS 90 0.0008
329 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
330 AFFECTIVE DISORDER 6 0.0008
331 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
332 BLOOD ALBUMIN DECREASED 6 0.0008
333 GASTROENTERITIS 11 0.0008
334 MACULAR DEGENERATION 9 0.0008
335 DYSSTASIA 22 0.0008
336 HYPERLIPIDAEMIA 9 0.0008
337 CHROMATURIA 17 0.0008
338 DEMENTIA 21 0.0008
339 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
340 HIP FRACTURE 24 0.0007
341 MUSCLE DISORDER 6 0.0007
342 RENAL INJURY 22 0.0007
343 SPINAL DISORDER 7 0.0007
344 CHRONIC KIDNEY DISEASE 56 0.0007
345 PRODUCT PACKAGING ISSUE 7 0.0007
346 HYPOKALAEMIA 34 0.0007
347 UNRESPONSIVE TO STIMULI 19 0.0007
348 DRUG ERUPTION 13 0.0007
349 MEMORY IMPAIRMENT 100 0.0007
350 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
351 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
352 INTESTINAL ISCHAEMIA 4 0.0007
353 SEPSIS 81 0.0007
354 ECONOMIC PROBLEM 11 0.0007
355 ILEUS 9 0.0007
356 ENCEPHALITIS 5 0.0007
357 GASTRITIS 19 0.0007
358 HEMIPLEGIA 6 0.0007
359 DEPRESSED MOOD 38 0.0007
360 GAIT INABILITY 24 0.0007
361 INTESTINAL OBSTRUCTION 27 0.0007
362 RESTLESS LEGS SYNDROME 13 0.0007
363 HEART RATE DECREASED 25 0.0007
364 INFUSION SITE ERYTHEMA 6 0.0007
365 STATUS EPILEPTICUS 8 0.0007
366 BLOOD PRESSURE FLUCTUATION 17 0.0007
367 GASTROOESOPHAGEAL REFLUX DISEASE 57 0.0007
368 BASAL CELL CARCINOMA 11 0.0007
369 HYPERTONIA 4 0.0007
370 INFUSION SITE PAIN 9 0.0007
371 SKIN HYPERPIGMENTATION 6 0.0007
372 CELLULITIS 35 0.0007
373 OBESITY 11 0.0007
374 PLATELET COUNT INCREASED 9 0.0007
375 DYSKINESIA 28 0.0007
376 HYPOTHYROIDISM 22 0.0007
377 SLUGGISHNESS 7 0.0007
378 MOVEMENT DISORDER 22 0.0007
379 BEDRIDDEN 9 0.0007
380 MAJOR DEPRESSION 5 0.0007
381 OSTEOARTHRITIS 29 0.0007
382 HYPERTRIGLYCERIDAEMIA 4 0.0007
383 SPINAL OSTEOARTHRITIS 6 0.0007
384 SPINAL PAIN 8 0.0007
385 GRIP STRENGTH DECREASED 6 0.0007
386 HAEMOGLOBIN DECREASED 70 0.0007
387 LYMPHOCYTE COUNT DECREASED 12 0.0007
388 COVID-19 PNEUMONIA 8 0.0007
389 LOWER LIMB FRACTURE 13 0.0007
390 SINUSITIS 69 0.0007
391 HERNIA 13 0.0007
392 GASTROINTESTINAL HAEMORRHAGE 56 0.0007
393 STAPHYLOCOCCAL INFECTION 22 0.0007
394 SINUS CONGESTION 9 0.0007
395 MOUTH ULCERATION 14 0.0007
396 OSTEOMYELITIS 12 0.0007
397 KIDNEY INFECTION 13 0.0007
398 TENDON PAIN 5 0.0007
399 END STAGE RENAL DISEASE 12 0.0007
400 SKIN LESION 18 0.0007
401 PERICARDITIS 11 0.0007
402 RENAL FAILURE CHRONIC 5 0.0006
403 BACK PAIN 151 0.0006
404 PRODUCT DISTRIBUTION ISSUE 6 0.0006
405 ANKLE FRACTURE 10 0.0006
406 FEMUR FRACTURE 20 0.0006
407 CONTUSION 62 0.0006
408 BACK INJURY 7 0.0006
409 CARPAL TUNNEL SYNDROME 9 0.0006
410 DIZZINESS 320 0.0006
411 LYMPHOPENIA 9 0.0006
412 COLITIS 24 0.0006
413 FURUNCLE 5 0.0006
414 RESPIRATORY TRACT CONGESTION 10 0.0006
415 PRODUCTIVE COUGH 30 0.0006
416 PRODUCT DOSE OMISSION 41 0.0006
417 SCIATICA 10 0.0006
418 NECK PAIN 35 0.0006
419 COLD SWEAT 11 0.0006
420 RHABDOMYOLYSIS 26 0.0006
421 MOOD ALTERED 17 0.0006
422 MYELODYSPLASTIC SYNDROME 9 0.0006
423 EAR PAIN 12 0.0006
424 HAEMORRHOIDS 12 0.0006
425 BACK DISORDER 10 0.0006
426 DECUBITUS ULCER 5 0.0006
427 MEDICATION ERROR 34 0.0006
428 RENAL TUBULAR NECROSIS 6 0.0006
429 KNEE OPERATION 6 0.0006
430 FLUID RETENTION 31 0.0006
431 SLEEP DISORDER 43 0.0006
432 ESCHERICHIA INFECTION 5 0.0006
433 DYSGRAPHIA 4 0.0006
434 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
435 PULMONARY CONGESTION 8 0.0006
436 HAEMATOCRIT DECREASED 12 0.0006
437 CATARACT 36 0.0006
438 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
439 PERIPHERAL SWELLING 93 0.0006
440 FLUSHING 61 0.0006
441 EYE HAEMORRHAGE 8 0.0006
442 PNEUMONIA 194 0.0006
443 HAIR TEXTURE ABNORMAL 8 0.0006
444 ROAD TRAFFIC ACCIDENT 25 0.0006
445 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
446 OSTEOPENIA 9 0.0006
447 HEPATIC STEATOSIS 11 0.0006
448 BLOOD IRON DECREASED 7 0.0006
449 NIGHT SWEATS 19 0.0006
450 ASTHENIA 220 0.0006
451 SCAR 10 0.0006
452 HAEMATURIA 20 0.0006
453 EMOTIONAL DISORDER 18 0.0006
454 MUSCULOSKELETAL CHEST PAIN 9 0.0006
455 ANURIA 5 0.0006
456 FOOT FRACTURE 11 0.0006
457 SYNCOPE 58 0.0006
458 BLOOD MAGNESIUM DECREASED 5 0.0006
459 NIGHTMARE 20 0.0006
460 CARDIAC MURMUR 5 0.0006
461 PANIC ATTACK 21 0.0006
462 PRESYNCOPE 14 0.0006
463 TENDERNESS 6 0.0006
464 BLOOD PRESSURE INCREASED 88 0.0006
465 DRUG EFFECT DECREASED 31 0.0006
466 ACUTE KIDNEY INJURY 88 0.0006
467 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
468 ACUTE RESPIRATORY FAILURE 11 0.0006
469 JOINT SWELLING 69 0.0006
470 OEDEMA 31 0.0006
471 SOMNOLENCE 115 0.0006
472 VIRAL INFECTION 19 0.0006
473 SPINAL OPERATION 7 0.0006
474 ABNORMAL WEIGHT GAIN 7 0.0006
475 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
476 CYST 7 0.0006
477 BREAST PAIN 6 0.0006
478 OROPHARYNGEAL PAIN 52 0.0006
479 HEREDITARY ANGIOEDEMA 6 0.0006
480 SECRETION DISCHARGE 7 0.0006
481 RENAL DISORDER 26 0.0006
482 WHEEZING 33 0.0006
483 SINUS DISORDER 11 0.0006
484 PRURITUS GENERALISED 12 0.0006
485 DEHYDRATION 74 0.0006
486 BRONCHITIS 41 0.0006
487 RASH PRURITIC 30 0.0006
488 AMNESIA 36 0.0006
489 INJECTION SITE IRRITATION 7 0.0005
490 SPINAL FRACTURE 11 0.0005
491 TREMOR 91 0.0005
492 MUSCULOSKELETAL STIFFNESS 48 0.0005
493 EXOSTOSIS 5 0.0005
494 FULL BLOOD COUNT DECREASED 11 0.0005
495 PRODUCT PRESCRIBING ERROR 13 0.0005
496 MYDRIASIS 7 0.0005
497 NEPHROLITHIASIS 25 0.0005
498 FATIGUE 424 0.0005
499 BRAIN NEOPLASM 5 0.0005
500 ANOREXIA 7 0.0005
501 BLINDNESS TRANSIENT 4 0.0005
502 GRAND MAL CONVULSION 5 0.0005
503 CEREBRAL DISORDER 4 0.0005
504 SKIN DISORDER 18 0.0005
505 BODY TEMPERATURE INCREASED 11 0.0005
506 LOSS OF CONSCIOUSNESS 69 0.0005
507 COUGH 151 0.0005
508 PERSONALITY CHANGE 5 0.0005
509 PULMONARY MASS 8 0.0005
510 GLOSSODYNIA 12 0.0005
511 NEPHROPATHY 5 0.0005
512 DIARRHOEA HAEMORRHAGIC 5 0.0005
513 HYPOAESTHESIA 80 0.0005
514 OCULAR DISCOMFORT 6 0.0005
515 JOINT STIFFNESS 14 0.0005
516 FACE OEDEMA 9 0.0005
517 BLOOD CALCIUM DECREASED 6 0.0005
518 FLANK PAIN 5 0.0005
519 OEDEMA PERIPHERAL 65 0.0005
520 ARTERIOSCLEROSIS 5 0.0005
521 TOOTH LOSS 11 0.0005
522 COVID-19 93 0.0005
523 SARS-COV-2 TEST POSITIVE 7 0.0005
524 PANCREATITIS 28 0.0005
525 CIRCULATORY COLLAPSE 9 0.0005
526 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
527 BLOOD COUNT ABNORMAL 8 0.0005
528 BURNING SENSATION 37 0.0005
529 INTENTIONAL DOSE OMISSION 15 0.0005
530 PAIN IN EXTREMITY 155 0.0005
531 CHOLECYSTECTOMY 6 0.0005
532 HYPERTHERMIA 4 0.0005
533 ANGINA PECTORIS 15 0.0005
534 INSURANCE ISSUE 8 0.0005
535 KNEE ARTHROPLASTY 11 0.0005
536 BOWEL MOVEMENT IRREGULARITY 4 0.0005
537 SKIN DISCOLOURATION 24 0.0005
538 DISSOCIATION 4 0.0005
539 THYROID DISORDER 8 0.0005
540 CHOLELITHIASIS 17 0.0005
541 ATRIOVENTRICULAR BLOCK 4 0.0005
542 LIMB DISCOMFORT 16 0.0005
543 BLISTER 29 0.0005
544 PNEUMONITIS 14 0.0005
545 MIGRAINE 49 0.0005
546 CHOKING 10 0.0005
547 DECREASED APPETITE 119 0.0005
548 MUSCLE SPASMS 94 0.0005
549 TREATMENT NONCOMPLIANCE 28 0.0005
550 SEXUAL DYSFUNCTION 6 0.0005
551 OSTEOPOROSIS 21 0.0005
552 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
553 PARAESTHESIA 80 0.0005
554 ATAXIA 6 0.0005
555 BACTERAEMIA 6 0.0005
556 ABDOMINAL PAIN UPPER 104 0.0005
557 PROCEDURAL PAIN 14 0.0005
558 DYSPNOEA EXERTIONAL 19 0.0005
559 INABILITY TO AFFORD MEDICATION 5 0.0005
560 RASH ERYTHEMATOUS 24 0.0005
561 GOUT 9 0.0005
562 HYPOTONIA 5 0.0005
563 DIPLOPIA 13 0.0005
564 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
565 TOOTHACHE 9 0.0005
566 DEPRESSION 113 0.0005
567 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
568 SURGERY 29 0.0005
569 BURSITIS 6 0.0005
570 MUSCLE TIGHTNESS 8 0.0005
571 NASAL CONGESTION 29 0.0005
572 INFLUENZA 55 0.0005
573 FEEDING DISORDER 10 0.0005
574 ATRIAL FIBRILLATION 48 0.0005
575 GENERAL PHYSICAL HEALTH DETERIORATION 57 0.0005
576 HAEMATOCHEZIA 27 0.0005
577 WHITE BLOOD CELL COUNT DECREASED 53 0.0005
578 HYPERSOMNIA 14 0.0005
579 CARDIOMEGALY 6 0.0005
580 HERPES ZOSTER 28 0.0005
581 BLOOD GLUCOSE ABNORMAL 9 0.0005
582 HEART RATE IRREGULAR 11 0.0005
583 DIARRHOEA 314 0.0005
584 VOMITING 228 0.0005
585 GENERALISED OEDEMA 6 0.0005
586 AGRANULOCYTOSIS 9 0.0005
587 POOR VENOUS ACCESS 5 0.0005
588 BLOOD PRESSURE DECREASED 32 0.0005
589 HYPERTENSION 102 0.0005
590 WEIGHT DECREASED 134 0.0005
591 RESPIRATORY FAILURE 35 0.0005
592 AGGRESSION 24 0.0005
593 TRANSFUSION 5 0.0005
594 PSYCHOTIC DISORDER 14 0.0005
595 SCRATCH 5 0.0005
596 INFLUENZA LIKE ILLNESS 39 0.0005
597 FULL BLOOD COUNT ABNORMAL 5 0.0005
598 TACHYCARDIA 42 0.0005
599 FEELING JITTERY 9 0.0005
600 INCREASED APPETITE 9 0.0005
601 CONDITION AGGRAVATED 143 0.0005
602 PULMONARY FIBROSIS 9 0.0005
603 DIVERTICULITIS 13 0.0005
604 RETCHING 10 0.0005
605 THROAT IRRITATION 21 0.0005
606 RESPIRATORY DISORDER 14 0.0005
607 DYSPEPSIA 46 0.0005
608 GLAUCOMA 9 0.0005
609 HAEMOPTYSIS 13 0.0005
610 ARRHYTHMIA 22 0.0005
611 HYPOAESTHESIA ORAL 7 0.0005
612 SKIN ULCER 12 0.0005
613 HYPOTENSION 93 0.0005
614 CORONARY ARTERY DISEASE 14 0.0005
615 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
616 RESPIRATORY TRACT INFECTION 12 0.0005
617 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
618 SEIZURE 53 0.0005
619 HEADACHE 287 0.0005
620 ANXIETY 130 0.0005
621 ANHEDONIA 12 0.0005
622 EOSINOPHILIA 8 0.0005
623 BLOOD GLUCOSE FLUCTUATION 5 0.0005
624 EYE DISORDER 15 0.0005
625 ABDOMINAL PAIN 106 0.0005
626 RED BLOOD CELL COUNT DECREASED 13 0.0005
627 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
628 MELAENA 10 0.0005
629 HYPOXIA 16 0.0005
630 HYPOGLYCAEMIA 22 0.0005
631 BLOOD PRESSURE ABNORMAL 9 0.0005
632 WITHDRAWAL SYNDROME 19 0.0005
633 UPPER LIMB FRACTURE 9 0.0005
634 VISUAL ACUITY REDUCED 15 0.0005
635 PRESCRIBED UNDERDOSE 9 0.0005
636 NERVE INJURY 5 0.0004
637 CHEST DISCOMFORT 46 0.0004
638 LUNG DISORDER 22 0.0004
639 SWOLLEN TONGUE 14 0.0004
640 DYSPNOEA 253 0.0004
641 INSOMNIA 119 0.0004
642 ORAL PAIN 10 0.0004
643 THERAPEUTIC PRODUCT EFFECT DECREASED 20 0.0004
644 PRODUCT USE COMPLAINT 7 0.0004
645 RENAL FAILURE 59 0.0004
646 THROAT TIGHTNESS 12 0.0004
647 CHEST PAIN 82 0.0004
648 LEUKOCYTOSIS 8 0.0004
649 AGEUSIA 11 0.0004
650 DRUG EFFECT INCOMPLETE 16 0.0004
651 C-REACTIVE PROTEIN INCREASED 16 0.0004
652 GINGIVAL BLEEDING 6 0.0004
653 MYOCARDIAL ISCHAEMIA 5 0.0004
654 MUSCULOSKELETAL PAIN 23 0.0004
655 HOT FLUSH 33 0.0004
656 AGITATION 32 0.0004
657 PERITONITIS 9 0.0004
658 RHINORRHOEA 28 0.0004
659 ARTHRITIS 34 0.0004
660 PULMONARY HYPERTENSION 9 0.0004
661 DERMATITIS 9 0.0004
662 BLOOD CREATININE INCREASED 28 0.0004
663 ALOPECIA 84 0.0004
664 PLEURAL EFFUSION 26 0.0004
665 DEVICE OCCLUSION 6 0.0004
666 MANIA 7 0.0004
667 PHOTOSENSITIVITY REACTION 7 0.0004
668 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
669 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
670 THERAPY NON-RESPONDER 19 0.0004
671 PULMONARY EMBOLISM 40 0.0004
672 DRY EYE 21 0.0004
673 DEAFNESS 11 0.0004
674 BRONCHOSPASM 6 0.0004
675 MUSCULOSKELETAL DISORDER 8 0.0004
676 FUNGAL INFECTION 14 0.0004
677 COMPLETED SUICIDE 35 0.0004
678 IRRITABLE BOWEL SYNDROME 9 0.0004
679 PARALYSIS 6 0.0004
680 RECTAL HAEMORRHAGE 18 0.0004
681 NASOPHARYNGITIS 77 0.0004
682 FAECES DISCOLOURED 9 0.0004
683 HYPERTHYROIDISM 6 0.0004
684 HYPERCHOLESTEROLAEMIA 4 0.0004
685 LOCALISED INFECTION 10 0.0004
686 CEREBROVASCULAR ACCIDENT 70 0.0004
687 DIZZINESS POSTURAL 4 0.0004
688 MYALGIA 70 0.0004
689 CARDIAC FAILURE 33 0.0004
690 HEPATIC ENZYME INCREASED 28 0.0004
691 ORAL HERPES 8 0.0004
692 CHILLS 48 0.0004
693 OXYGEN SATURATION DECREASED 23 0.0004
694 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
695 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
696 MUSCULOSKELETAL DISCOMFORT 7 0.0004
697 LABORATORY TEST ABNORMAL 12 0.0004
698 PARANOIA 7 0.0004
699 CARDIOMYOPATHY 6 0.0004
700 TENDON RUPTURE 5 0.0004
701 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
702 OSTEONECROSIS OF JAW 10 0.0004
703 EMBEDDED DEVICE 4 0.0004
704 EYE SWELLING 15 0.0004
705 PHARYNGITIS 5 0.0004
706 NAUSEA 319 0.0004
707 LOCAL SWELLING 7 0.0004
708 RASH MACULAR 14 0.0004
709 RESPIRATORY DISTRESS 11 0.0004
710 ABNORMAL DREAMS 11 0.0004
711 ARTHRALGIA 165 0.0004
712 PRODUCT PHYSICAL ISSUE 8 0.0004
713 DEVICE FAILURE 6 0.0004
714 SUICIDAL IDEATION 36 0.0004
715 ANAEMIA 75 0.0004
716 FEELING ABNORMAL 94 0.0004
717 GALLBLADDER DISORDER 7 0.0004
718 EAR DISCOMFORT 4 0.0004
719 ERECTILE DYSFUNCTION 10 0.0004
720 ROTATOR CUFF SYNDROME 5 0.0004
721 LYMPHOMA 6 0.0004
722 FLATULENCE 22 0.0004
723 RASH GENERALISED 10 0.0004
724 BLOOD CHOLESTEROL INCREASED 18 0.0004
725 INJECTION SITE INDURATION 5 0.0004
726 MALAISE 169 0.0004
727 ANGER 13 0.0004
728 CYANOSIS 6 0.0004
729 ORAL CANDIDIASIS 5 0.0004
730 ILLNESS 39 0.0004
731 INTENTIONAL PRODUCT USE ISSUE 33 0.0004
732 EATING DISORDER 8 0.0004
733 ABDOMINAL DISCOMFORT 63 0.0004
734 JOINT INJURY 8 0.0004
735 CARDIAC FAILURE CONGESTIVE 30 0.0004
736 MALIGNANT MELANOMA 5 0.0004
737 ACUTE MYOCARDIAL INFARCTION 11 0.0004
738 HYPERSENSITIVITY 69 0.0004
739 ASTHMA 42 0.0004
740 SKIN CANCER 8 0.0004
741 FIBROMYALGIA 9 0.0004
742 PSORIATIC ARTHROPATHY 15 0.0004
743 BLOOD POTASSIUM INCREASED 6 0.0004
744 INFECTION 53 0.0004
745 METASTASES TO BONE 6 0.0004
746 PRODUCT SUBSTITUTION ISSUE 21 0.0004
747 DRUG INEFFECTIVE 480 0.0004
748 PERIPHERAL COLDNESS 5 0.0004
749 THERAPY INTERRUPTED 26 0.0004
750 GASTROINTESTINAL PAIN 4 0.0004
751 INJECTION SITE NODULE 4 0.0004
752 VENTRICULAR TACHYCARDIA 6 0.0004
753 PAIN 223 0.0004
754 WEIGHT INCREASED 81 0.0004
755 DENTAL CARIES 4 0.0004
756 EPISTAXIS 27 0.0004
757 COAGULOPATHY 6 0.0004
758 STEVENS-JOHNSON SYNDROME 8 0.0004
759 ORAL DISCOMFORT 5 0.0004
760 FEELING COLD 10 0.0004
761 PYREXIA 124 0.0004
762 OCULAR HYPERAEMIA 17 0.0004
763 WOUND 10 0.0004
764 CRYING 13 0.0004
765 NEUROPATHY PERIPHERAL 34 0.0004
766 RASH PAPULAR 8 0.0004
767 PLATELET COUNT DECREASED 38 0.0004
768 TYPE 2 DIABETES MELLITUS 12 0.0004
769 PANCREATITIS ACUTE 8 0.0004
770 BLOOD TEST ABNORMAL 5 0.0004
771 CANDIDA INFECTION 6 0.0004
772 RESTLESSNESS 13 0.0004
773 EYE INFECTION 4 0.0004
774 DISABILITY 7 0.0004
775 HEART RATE INCREASED 35 0.0004
776 SWELLING FACE 23 0.0004
777 INTERSTITIAL LUNG DISEASE 17 0.0004
778 DERMATITIS CONTACT 4 0.0004
779 INTERNAL HAEMORRHAGE 4 0.0003
780 TINNITUS 16 0.0003
781 THROMBOSIS 28 0.0003
782 PRURITUS 133 0.0003
783 MOOD SWINGS 11 0.0003
784 TASTE DISORDER 7 0.0003
785 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
786 ELECTROLYTE IMBALANCE 4 0.0003
787 SEDATION 9 0.0003
788 APATHY 5 0.0003
789 DRUG INTOLERANCE 33 0.0003
790 HYPERHIDROSIS 44 0.0003
791 BONE PAIN 20 0.0003
792 BRADYCARDIA 18 0.0003
793 VISUAL IMPAIRMENT 42 0.0003
794 SKIN HAEMORRHAGE 5 0.0003
795 PRODUCT DOSE OMISSION ISSUE 99 0.0003
796 DYSGEUSIA 25 0.0003
797 THIRST 6 0.0003
798 IMMUNODEFICIENCY 5 0.0003
799 ACCIDENT 4 0.0003
800 JAUNDICE 9 0.0003
801 RENAL IMPAIRMENT 28 0.0003
802 BLOOD BILIRUBIN INCREASED 9 0.0003
803 SYNOVITIS 6 0.0003
804 FEELING HOT 20 0.0003
805 NERVOUSNESS 17 0.0003
806 POOR QUALITY SLEEP 7 0.0003
807 PANCYTOPENIA 18 0.0003
808 PRODUCT PRESCRIBING ISSUE 7 0.0003
809 DRUG DOSE OMISSION 53 0.0003
810 INJECTION SITE DISCOLOURATION 4 0.0003
811 TARDIVE DYSKINESIA 9 0.0003
812 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
813 BRAIN OEDEMA 4 0.0003
814 ABDOMINAL PAIN LOWER 8 0.0003
815 PNEUMOTHORAX 5 0.0003
816 HALLUCINATION, AUDITORY 5 0.0003
817 HEPATITIS 8 0.0003
818 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
819 DISCOMFORT 19 0.0003
820 RHEUMATOID ARTHRITIS 35 0.0003
821 DEEP VEIN THROMBOSIS 20 0.0003
822 PRODUCT AVAILABILITY ISSUE 7 0.0003
823 SKIN FISSURES 6 0.0003
824 ABDOMINAL DISTENSION 32 0.0003
825 ASCITES 9 0.0003
826 IMPAIRED HEALING 10 0.0003
827 SHOCK 7 0.0003
828 MULTIPLE FRACTURES 5 0.0003
829 UNEVALUABLE EVENT 23 0.0003
830 DIABETES MELLITUS 23 0.0003
831 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
832 EXPIRED PRODUCT ADMINISTERED 10 0.0003
833 BREAST CANCER FEMALE 8 0.0003
834 MENTAL DISORDER 13 0.0003
835 PAIN OF SKIN 8 0.0003
836 STOMATITIS 18 0.0003
837 ERYTHEMA 61 0.0003
838 FREQUENT BOWEL MOVEMENTS 8 0.0003
839 EYE IRRITATION 17 0.0003
840 PULMONARY OEDEMA 13 0.0003
841 RESPIRATORY ARREST 8 0.0003
842 ADVERSE DRUG REACTION 26 0.0003
843 CARDIO-RESPIRATORY ARREST 12 0.0003
844 ECZEMA 15 0.0003
845 CEREBRAL INFARCTION 7 0.0003
846 PRODUCT USE IN UNAPPROVED INDICATION 71 0.0003
847 ENCEPHALOPATHY 7 0.0003
848 BLINDNESS UNILATERAL 4 0.0003
849 LYMPHADENOPATHY 10 0.0003
850 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
851 ILL-DEFINED DISORDER 17 0.0003
852 GASTROINTESTINAL DISORDER 25 0.0003
853 CARDIOGENIC SHOCK 4 0.0003
854 RASH 121 0.0003
855 HAEMORRHAGE 29 0.0003
856 ANOSMIA 4 0.0003
857 PELVIC PAIN 5 0.0003
858 HYPOPHAGIA 7 0.0003
859 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49 0.0003
860 COLON CANCER 4 0.0003
861 CARDIAC ARREST 22 0.0003
862 IRRITABILITY 16 0.0003
863 PRODUCT USE ISSUE 50 0.0003
864 LACRIMATION INCREASED 8 0.0003
865 FRACTURE 5 0.0003
866 EAR INFECTION 7 0.0003
867 URTICARIA 44 0.0003
868 DRUG DISPENSING ERROR 4 0.0003
869 INJECTION SITE REACTION 18 0.0003
870 INJECTION SITE RASH 8 0.0003
871 PSORIASIS 34 0.0003
872 FEAR 7 0.0003
873 DRUG PRESCRIBING ERROR 5 0.0003
874 PERICARDIAL EFFUSION 6 0.0003
875 SWELLING 24 0.0003
876 NERVOUS SYSTEM DISORDER 8 0.0003
877 BRAIN FOG 4 0.0003
878 NEOPLASM MALIGNANT 17 0.0003
879 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
880 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
881 COMA 12 0.0003
882 THROMBOCYTOPENIA 28 0.0003
883 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
884 EMOTIONAL DISTRESS 30 0.0002
885 COLITIS ULCERATIVE 11 0.0002
886 CARDIAC DISORDER 23 0.0002
887 CONVULSION 14 0.0002
888 OFF LABEL USE 212 0.0002
889 DRUG LEVEL INCREASED 4 0.0002
890 HOSPITALISATION 37 0.0002
891 CYTOMEGALOVIRUS INFECTION 4 0.0002
892 BLOOD GLUCOSE INCREASED 45 0.0002
893 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
894 BREAST CANCER 22 0.0002
895 IMPAIRED WORK ABILITY 5 0.0002
896 ARTHROPATHY 13 0.0002
897 INTENTIONAL OVERDOSE 15 0.0002
898 LIVER FUNCTION TEST INCREASED 5 0.0002
899 DRY SKIN 31 0.0002
900 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
901 SUICIDE ATTEMPT 14 0.0002
902 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
903 DEVICE DISLOCATION 10 0.0002
904 FEBRILE NEUTROPENIA 15 0.0002
905 LIVER DISORDER 10 0.0002
906 TOOTH DISORDER 5 0.0002
907 RASH MACULO-PAPULAR 5 0.0002
908 BONE DENSITY DECREASED 7 0.0002
909 SNEEZING 5 0.0002
910 PALLOR 6 0.0002
911 METABOLIC ACIDOSIS 7 0.0002
912 SKIN IRRITATION 10 0.0002
913 ANAPHYLACTIC REACTION 12 0.0002
914 INJURY 15 0.0002
915 HEPATIC CIRRHOSIS 4 0.0002
916 HYPOCALCAEMIA 4 0.0002
917 INFUSION RELATED REACTION 14 0.0002
918 HYPOACUSIS 9 0.0002
919 EYE PRURITUS 7 0.0002
920 DIABETIC KETOACIDOSIS 5 0.0002
921 TOXICITY TO VARIOUS AGENTS 35 0.0002
922 SEPTIC SHOCK 9 0.0002
923 ERUCTATION 4 0.0002
924 DYSTONIA 4 0.0002
925 NEEDLE ISSUE 6 0.0002
926 TREATMENT FAILURE 17 0.0002
927 DRUG WITHDRAWAL SYNDROME 18 0.0002
928 PLASMA CELL MYELOMA 8 0.0002
929 GASTRIC DISORDER 7 0.0002
930 LIVER INJURY 5 0.0002
931 SKIN EXFOLIATION 17 0.0002
932 EXTRAPYRAMIDAL DISORDER 5 0.0002
933 MYOCARDIAL INFARCTION 35 0.0002
934 NEUTROPENIA 27 0.0002
935 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
936 INCORRECT DOSE ADMINISTERED 45 0.0002
937 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
938 BLINDNESS 8 0.0002
939 SKIN BURNING SENSATION 14 0.0002
940 ADVERSE EVENT 18 0.0002
941 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
942 HYPERGLYCAEMIA 7 0.0002
943 ACCIDENTAL OVERDOSE 7 0.0002
944 MUCOSAL INFLAMMATION 5 0.0002
945 DEVICE ISSUE 17 0.0002
946 INJECTION SITE MASS 7 0.0002
947 INJECTION SITE BRUISING 15 0.0002
948 DISEASE PROGRESSION 22 0.0002
949 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
950 DEATH 155 0.0002
951 UNDERDOSE 13 0.0002
952 PANCREATIC CARCINOMA 5 0.0002
953 INTENTIONAL PRODUCT MISUSE 15 0.0002
954 LUNG NEOPLASM MALIGNANT 7 0.0002
955 DISEASE RECURRENCE 8 0.0002
956 INJECTION SITE PRURITUS 11 0.0002
957 INJECTION SITE URTICARIA 4 0.0002
958 DRUG ADMINISTRATION ERROR 5 0.0002
959 PRODUCT QUALITY ISSUE 22 0.0002
960 HEPATIC FUNCTION ABNORMAL 6 0.0002
961 DRUG-INDUCED LIVER INJURY 5 0.0002
962 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
963 CARDIOVASCULAR DISORDER 4 0.0002
964 APPLICATION SITE ERYTHEMA 4 0.0002
965 DERMATITIS ATOPIC 8 0.0002
966 ABNORMAL BEHAVIOUR 6 0.0002
967 EXTRA DOSE ADMINISTERED 6 0.0001
968 NEUTROPHIL COUNT DECREASED 6 0.0001
969 INJECTION SITE ERYTHEMA 18 0.0001
970 INJECTION SITE PAIN 44 0.0001
971 VAGINAL HAEMORRHAGE 6 0.0001
972 ANGIOEDEMA 6 0.0001
973 THERAPEUTIC RESPONSE DECREASED 8 0.0001
974 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
975 INJECTION SITE HAEMORRHAGE 10 0.0001
976 BLOOD GLUCOSE DECREASED 6 0.0001
977 OVERDOSE 26 0.0001
978 LEUKOPENIA 6 0.0001
979 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
980 PROSTATE CANCER 9 0.0001
981 DEVICE BREAKAGE 4 0.0001
982 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
983 INFLAMMATION 5 0.0001
984 INJECTION SITE SWELLING 7 0.0001
985 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
986 DEVICE MALFUNCTION 6 0.0001
987 ACNE 6 0.0001
988 DEVICE DIFFICULT TO USE 5 0.0001
989 BLADDER CANCER 4 0.0001
990 NO ADVERSE EVENT 12 0.0001
991 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
992 DRUG ABUSE 4 0.0000
993 DRUG DEPENDENCE 7 0.0000